HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin Yan Selected Research

dextran - saline drug combination (L-410)

4/2021M2 Macrophage-Derived Exosomal miR-590-3p Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via the LATS1/YAP/ β-Catenin Signalling Axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin Yan Research Topics

Disease

60Neoplasms (Cancer)
06/2022 - 09/2003
12Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2006
10Inflammation (Inflammations)
01/2022 - 08/2005
9Obesity
08/2022 - 01/2014
9Stomach Neoplasms (Stomach Cancer)
12/2021 - 03/2015
8Infections
01/2019 - 06/2004
7Melanoma (Melanoma, Malignant)
06/2022 - 05/2018
7Colonic Neoplasms (Colon Cancer)
01/2022 - 04/2016
7Breast Neoplasms (Breast Cancer)
03/2019 - 10/2011
7Pain (Aches)
10/2015 - 04/2007
6Carcinogenesis
01/2022 - 01/2015
6Neoplasm Metastasis (Metastasis)
12/2021 - 01/2016
6Colorectal Neoplasms (Colorectal Cancer)
08/2021 - 01/2013
6COVID-19
01/2021 - 01/2020
6Body Weight (Weight, Body)
01/2020 - 03/2015
5Insulin Resistance
01/2021 - 01/2013
5Migraine Disorders (Migraine)
10/2015 - 01/2011
5Hyperalgesia
09/2012 - 04/2007
5Schizophrenia (Dementia Praecox)
09/2009 - 07/2004
5Autistic Disorder (Autism)
09/2009 - 02/2005
4Headache (Headaches)
10/2015 - 01/2012
4Mental Disorders (Mental Disorder)
05/2005 - 03/2004
3Wounds and Injuries (Trauma)
03/2022 - 07/2016
3Hypertension (High Blood Pressure)
01/2022 - 11/2020
3Hypoxia (Hypoxemia)
11/2021 - 01/2019
3Hemorrhage
08/2021 - 09/2017
3Necrosis
04/2021 - 08/2017
3Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 08/2018
3Adenocarcinoma
01/2021 - 11/2012
3Dysbiosis
01/2021 - 01/2018
3Alcoholism (Alcohol Abuse)
03/2020 - 02/2005
3Multiple Organ Failure (MODS)
06/2018 - 04/2018
3Papillary Thyroid Cancer
05/2018 - 01/2014
3Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2017 - 12/2012
3Neurodegenerative Diseases (Neurodegenerative Disease)
09/2014 - 02/2008
3Rett Syndrome (Rett's Disorder)
01/2008 - 07/2004
2Weight Loss (Weight Reduction)
08/2022 - 08/2017
2Cytokine Release Syndrome
04/2022 - 01/2021
2Fibrosis (Cirrhosis)
01/2022 - 11/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 05/2018
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2022
2Metabolic Diseases (Metabolic Disease)
01/2022 - 01/2021
2Chronic Renal Insufficiency
01/2022 - 01/2020
2Disease Progression
01/2022 - 11/2020
2Ulcerative Colitis
04/2021 - 07/2016
2Thrombosis (Thrombus)
01/2021 - 06/2006
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 12/2014
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2011
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 01/2019
2Atherosclerosis
01/2021 - 09/2018
2Congenital Abnormalities (Deformity)
12/2020 - 09/2008
2Cough
11/2020 - 08/2020

Drug/Important Bio-Agent (IBA)

21Peptides (Polypeptides)IBA
06/2022 - 09/2008
21Proteins (Proteins, Gene)FDA Link
06/2022 - 06/2008
12Biomarkers (Surrogate Marker)IBA
04/2022 - 02/2014
11Pharmaceutical PreparationsIBA
06/2022 - 01/2018
10MicroRNAs (MicroRNA)IBA
01/2022 - 07/2009
10Long Noncoding RNAIBA
11/2021 - 01/2016
6CateninsIBA
06/2022 - 11/2018
6CytokinesIBA
01/2022 - 11/2010
5Glucose (Dextrose)FDA LinkGeneric
11/2021 - 08/2005
5Interleukin-6 (Interleukin 6)IBA
04/2021 - 11/2010
5Messenger RNA (mRNA)IBA
03/2019 - 04/2013
4Caspase 3 (Caspase-3)IBA
01/2022 - 01/2015
4LipidsIBA
01/2022 - 12/2018
4DNA (Deoxyribonucleic Acid)IBA
06/2021 - 07/2004
4Reactive Oxygen Species (Oxygen Radicals)IBA
06/2021 - 01/2017
4Triglycerides (Triacylglycerol)IBA
01/2021 - 03/2015
4Tumor Biomarkers (Tumor Markers)IBA
11/2019 - 01/2014
4Lanthanoid Series Elements (Lanthanides)IBA
09/2019 - 01/2018
4Biological ProductsIBA
03/2019 - 04/2014
3Environmental Pollutants (Pollutants, Environmental)IBA
08/2022 - 01/2017
3RNA (Ribonucleic Acid)IBA
01/2022 - 11/2016
3Circular RNAIBA
01/2022 - 01/2019
3Adenosine Monophosphate (AMP)IBA
01/2021 - 09/2011
3AntigensIBA
01/2018 - 06/2004
2Immune Checkpoint InhibitorsIBA
06/2022 - 12/2019
2MetalsIBA
06/2022 - 01/2022
2Disulfiram (Antabuse)FDA Link
03/2022 - 03/2020
2salvinIBA
01/2022 - 12/2019
2GoldIBA
01/2022 - 01/2021
2B7-H1 AntigenIBA
01/2022 - 01/2020
2MercuryIBA
01/2022 - 02/2017
2Ethanol (Ethyl Alcohol)IBA
01/2022 - 01/2014
2SolutionsIBA
12/2021 - 12/2011
2Oxygen (Dioxygen)IBA
11/2021 - 06/2021
2Anti-Bacterial Agents (Antibiotics)IBA
02/2021 - 01/2021
2Nonsense Codon (Nonsense Mutation)IBA
01/2021 - 09/2003
2Apolipoproteins E (ApoE)IBA
01/2021 - 09/2018
2EndosulfanIBA
01/2021 - 08/2017
2Glutathione (Reduced Glutathione)IBA
01/2021 - 08/2019
2Amino AcidsFDA Link
05/2020 - 08/2017
2InterleukinsIBA
01/2020 - 11/2018
2Silicon Dioxide (Silica)FDA LinkGeneric
08/2019 - 08/2019

Therapy/Procedure

30Therapeutics
06/2022 - 09/2011
8Immunotherapy
06/2022 - 12/2019
5Drug Therapy (Chemotherapy)
08/2021 - 03/2015
3Condoms (Condom)
01/2017 - 12/2012
2Lasers (Laser)
06/2021 - 03/2019
2Myotomy
03/2020 - 10/2019